Jaap Jan Zwaginga (J J Zwaginga, Jaap J Zwaginga)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Cells

Antibodies (Basel, Switzerland)

Transfusion

European journal of haematology

Leiden University Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leiden University Medical Center

Netherlands

hematologist :: Immunohematology and Bloodtransfusion

Publications

Romy T Meier, Leendert Porcelijn, Suzanne Hofstede-van Egmond, Camila Caram-Deelder, Jonathan M Coutinho, Yvonne M C Henskens, Marieke J H A Kruip, An K Stroobants, Jaap Jan Zwaginga, C Ellen Van Der Schoot, Masja de Haas, Rick Kapur
Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients. Antibodies (Basel, Switzerland) 13 (2) (2024)
Romy T Meier, Leendert Porcelijn, Suzanne Hofstede-van Egmond, Camila Caram-Deelder, Jonathan M Coutinho, Yvonne M C Henskens, Marieke J H A Kruip, An K Stroobants, Jaap Jan Zwaginga, C Ellen Van Der Schoot, Masja de Haas, Rick Kapur
Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients. Antibodies (Basel, Switzerland) 13 (2) (2024)
Chelsea Gootjes, Jaap Jan Zwaginga, Bart O Roep, Tatjana Nikolic
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function. Cells 13 (11) (2024)
Chelsea Gootjes, Jaap Jan Zwaginga, Bart O Roep, Tatjana Nikolic
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function. Cells 13 (11) (2024)
Chelsea Gootjes, Jaap Jan Zwaginga, Bart O Roep, Tatjana Nikolic
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function. Cells 13 (11) (2024)
Loes L Cornelissen, Aukje L Kreuger, Camila Caram-Deelder, Menno V Huisman, Rutger A Middelburg, Jean Louis H Kerkhoffs, Peter A von dem Borne, Erik A M Beckers, Karen M K de Vooght, Jürgen Kuball, Johanna van der Bom, Jaap Jan Zwaginga
Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia. European journal of haematology 108 (4) (2022)
Vivianne S Nelson, Anne-Tess C Jolink, Sufia N Amini, Jaap Jan Zwaginga, Tanja Netelenbos, John W Semple, Leendert Porcelijn, Masja de Haas, Martin R Schipperus, Rick Kapur
Platelets in ITP: Victims in Charge of Their Own Fate? Cells 10 (11) (2021)
Indu Khatri, Annieck M Diks, Erik Ben van den Akker, Liesbeth E M Oosten, Jaap Jan Zwaginga, Marcel J T Reinders, Jacques J M van Dongen, Magdalena A Berkowska
Longitudinal Dynamics of Human B-Cell Response at the Single-Cell Level in Response to Tdap Vaccination. Vaccines 9 (11) (2021)
Loes L Cornelissen, Camila Caram-Deelder, Susanna F Fustolo-Gunnink, Rolf H H Groenwold, Simon J Stanworth, Jaap Jan Zwaginga, Johanna van der Bom
Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks. Transfusion 61 (9) (2021)
Jessie S Luken, Claudia C Folman, Michaël V Lukens, Johan H Meekers, Peter C Ligthart, Henk Schonewille, Jaap Jan Zwaginga, Mart P Janssen, C Ellen Van Der Schoot, Johanna van der Bom, Masja De Haas
Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands. Transfusion 61 (3) (2021)
Loes L Cornelissen, Camila Caram-Deelder, Johanna van der Bom, Rutger A Middelburg, Jaap Jan Zwaginga
Risk factors for bleeding in haemato-oncology patients-a nested case-control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained). BMJ open 10 (6) (2020)
Loes L Cornelissen, Aukje L Kreuger, Camila Caram-Deelder, Rutger A Middelburg, Jean Louis H Kerkhoffs, Peter A von dem Borne, Erik A M Beckers, Karen M K de Vooght, Jürgen Kuball, Jaap Jan Zwaginga, Johanna van der Bom
Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia - a nested case-control study. Annals of hematology 100 (1) (2020)
Loes L Cornelissen, Camila Caram-Deelder, Romy T Meier, Jaap Jan Zwaginga, Dorothea Evers, null null
Platelet transfusion and tranexamic acid to prevent bleeding in outpatients with a hematological disease: A Dutch nationwide survey. European journal of haematology 106 (3) (2020)
Pieter F van der Meer, Paula F Ypma, Anna A van Geloven, Joost A van Hilten, Rinie J van Wordragen-Vlaswinkel, Okke Eissen, Jaap Jan Zwaginga, Michael Trus, Erik A M Beckers, Peter A W Te Boekhorst, Alan Tinmouth, Yulia Lin, Cyrus C Hsia, David Lee, Phillip J Norris, Raymond P Goodrich, Anneke Brand, Tor Audun Hervig, Nancy M Heddle, Johanna van der Bom, Jean-Louis H Kerkhoffs
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial. Blood 132 (2) (2018)

Jaap Jan Zwaginga.css-eqlu8i{font-size:small;padding-left:4px;} (J J Zwaginga, Jaap J Zwaginga)

Publication Activity (10 Years)

Top Topics

Top Venues

Jaap Jan Zwaginga (J J Zwaginga, Jaap J Zwaginga)